DNA & Genetics Avadel Sparks Bidding War; Agios Plummets 51% on Phase III DataBy adminNovember 23, 20250 More than two weeks after Pfizer (NYSE: PFE) and Novo Nordisk (NASDAQ Copenhagen: NOVO-B) slugged it out for Metsera (NASDAQ:…